| Description | Caplacizumab (ALX-0681), a humanized anti-von Willebrand factor (vWF) nanobody, serves to impede vWF-mediated platelet adhesion, thereby averting additional microthrombi formation. This compound is utilized in the study of thrombotic thrombocytopenic purpura (TTP) [1]. |
| Synonyms | ALX-0081, ALX-0681 |
| molecular weight | N/A |
| CAS | 915810-67-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |